Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#192 of 458

Caitlin Cronin

Canaccord Genuity · Equity Research Analyst
ProvisionalRating since 2023No new ratings since Aug 2025

Analyst rating accuracy & track record

Caitlin Cronin is an equity research analyst at Canaccord Genuity. Quantellect has scored 20 of their stock calls across 8 companies. Their picks beat their sector 40% of the time over the next 12 months, and their price targets were reached 50% of the time within a year.

Win % vs sector
40%
PT Hit % (12mo)
50%
Avg sector-excess
−3.3%
Scored calls
20
Tickers
8
Tier
Provisional

Track record

Quantellect has scored 20 of Caitlin Cronin's stock calls across 8 companies, dating back to 2023. Their rated stocks beat their own sector 40% of the time over the next 12 months. On a typical call, a Cronin pick returned −3.3% more than its sector over the following year.

Of the scored calls, 20 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ESTAEstablishment Labs Holdings Inc
Buy$60.00Aug 2025+51.4%Hit
ENOVEnovis Corp
Buy$58.00Aug 2025−44.7%Miss
VCELVericel Corp Ord
Buy$58.00Aug 2025−1.0%Miss
ATECAlphatec Holdings Inc
Buy$20.00Aug 2025−55.3%Hit
ENOVEnovis Corp
Buy$70.00May 2025−40.8%Miss
AXGNAxogen Inc
Buy$24.00May 2025+224.9%Hit
TELATela Bio Inc
Buy$7.00Mar 2025−40.9%Miss
BVSBioventus Inc
Buy$15.00Mar 2025−9.7%Miss
AXGNAxogen Inc
Buy$26.00Feb 2025+55.4%Hit
VCELVericel Corp Ord
Buy$67.00Feb 2025−44.2%Miss
AXGNAxogen Inc
Buy$22.00Feb 2025+88.1%Hit
VCELVericel Corp Ord
Buy$60.00Nov 2024−40.5%Hit
KRMDRepro Med Systems Inc
Buy$4.00Nov 2024+27.3%Hit
TELATela Bio Inc
Buy$12.00Oct 2024−39.3%Miss
TELATela Bio Inc
Buy$12.00Aug 2024−41.0%Miss
VCELVericel Corp Ord
Buy$57.00Aug 2024−10.7%Hit
TELATela Bio Inc
Buy$14.00Jul 2024−50.8%Miss
AXGNAxogen Inc
Buy$15.00Jun 2024+47.2%Hit
KRMDRepro Med Systems Inc
Buy$3.00Dec 2023+48.4%Hit
AXGNAxogen Inc
Buy$11.00Dec 2023+87.6%Hit
Prev1Next
Go to

Caitlin Cronin: analyst track record FAQ

Is Caitlin Cronin a good stock analyst?

Yes, by track record. Caitlin Cronin ranks number 192 of 458 of the analysts Quantellect scores, with a Q Score of 40 out of 100. Past results do not guarantee future ones.

What is Caitlin Cronin's win rate?

Caitlin Cronin's win rate is 40%. Across 20 scored calls, their rated stocks beat their sector 40% of the time over the next 12 months. On a typical call they returned −3.3% more than the sector.

What stocks and sectors does Caitlin Cronin cover?

Caitlin Cronin covers 8 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Caitlin Cronin's price targets accurate?

Caitlin Cronin's price targets are reached within 12 months 50% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Caitlin Cronin's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Caitlin Cronin rank among Wall Street analysts?

Caitlin Cronin ranks number 192 of 458 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.